An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
ClinicalTrials.gov · NCT01511393 · Registry updated: 2023-06-13
- Condition / research focus
- Diabetes; Diabetes Mellitus, Type 2; Medullary Thyroid Carcinoma; Weight Management
- Sponsor
- Novo Nordisk A/S
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2012-01. Completion: 2039-12 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- No treatment given (other)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- United BioSource, LLC
Morgantown, West Virginia, United States
Site recruitment: Not reported